Suppr超能文献

[促性腺激素释放激素作为诊断剂在一步法和两步法试验中的临床应用]

[Clinical use of Gonadorelin as a diagnostic agent in one- and two-step tests].

作者信息

Vesper B, Rohde W, Groot-Wassink T

出版信息

Zentralbl Gynakol. 1986;108(23):1442-52.

PMID:3103350
Abstract

Synthetic LH/RH Gonadorelin, produced by VEB Berlin-Chemie, was given to 11 women with a normal menstrual cycle during the middle of the follicle phase. It was proved as a very effective drug, which provoked a typical gonadotropin release. Also 10 patients with a secondary amenorrhea responded already to the first intravenous injection of 80 micrograms Gonadorelin with a peak level of gonadotropins, in particular with LH levels, after 30 to 60 minutes (delta 1 = 1 st peak level--0' level). The relative ascent of gonadotropins (delta 2 = 2nd peak level--120' level) after the second step i.v. administration of 80 micrograms Gonadorelin at a 120 minutes interval was not significantly higher than delta 1. The reaction of pituitary on LH/RH does not immediately depend on the basal level of gonadotropin values. It reflects the severity of the hypothalamic-pituitary functional disturbance. The "Gonadorelin-test" ist a good complement to the progesterone- and clomiphene-test.

摘要

由东德科学院柏林化学制药厂生产的合成促黄体激素释放激素(LH/RH)戈那瑞林,在卵泡期中期给予11名月经周期正常的女性。结果证明它是一种非常有效的药物,能引发典型的促性腺激素释放。另外,10名继发性闭经患者在首次静脉注射80微克戈那瑞林后,30至60分钟时促性腺激素达到峰值水平,尤其是促黄体生成素(LH)水平(δ1 = 第一个峰值水平 - 0' 水平)。在120分钟间隔时第二步静脉注射80微克戈那瑞林后,促性腺激素的相对上升幅度(δ2 = 第二个峰值水平 - 120' 水平)并不显著高于δ1。垂体对LH/RH的反应并不直接取决于促性腺激素值的基础水平。它反映了下丘脑 - 垂体功能紊乱的严重程度。“戈那瑞林试验”是对孕酮试验和克罗米芬试验的良好补充。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验